Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Karstoft

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Patient Preference and Adherence|February 14, 2024
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse EffectsThomas Leth Jensen, Andreas Brønden, Kristian Karstoft, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 29, 2014
Insulin sensitivity is independent of lipid binding protein trafficking at the plasma membrane in human skeletal muscle: effect of a 3-day, high-fat dietAndreas B Jordy, Annette K Serup, Kristian Karstoft, et al.
Journal of Cancer Policy|November 7, 2025
Discrepancies in the therapeutic indications granted by the European Medicines Agency and the US Food and Drug Administration for new cancer drugs: An analysis of potential explanationsAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
The Lancet. Oncology|September 1, 2023
Withdrawn accelerated approvals for cancer indications in the USA: what is the marketing authorisation status in the EU?Allan Cramer, Freja K H Sørup, Hanne R Christensen, et al.
Frontiers in Endocrinology|June 30, 2017
Resting Metabolic Rate Does Not Change in Response to Different Types of Training in Subjects with Type 2 DiabetesKristian Karstoft, Cecilie Fau Brinkløv, Ida Kær Thorsen, et al.
British Journal of Clinical Pharmacology|January 8, 2025
Cancer drug applications to the EMA and the FDA: A comparison of new drugs and extension of indication in terms of approval decisions and time in reviewAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
JAMA Internal Medicine|July 3, 2013
The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitusThomas P J Solomon, Steven K Malin, Kristian Karstoft, et al.
Physiological Reports|August 30, 2014
The immediate effects of a single bout of aerobic exercise on oral glucose tolerance across the glucose tolerance continuumSine H Knudsen, Kristian Karstoft, Bente K Pedersen, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 31, 2007
Different strategies for MRI measurements of renal cortical volumeKristian Karstoft, Anders B Lødrup, Thomas H Dissing, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicityThomas P J Solomon, Sine H Knudsen, Kristian Karstoft, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Patient Preference and Adherence|February 14, 2024
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse EffectsThomas Leth Jensen, Andreas Brønden, Kristian Karstoft, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 29, 2014
Insulin sensitivity is independent of lipid binding protein trafficking at the plasma membrane in human skeletal muscle: effect of a 3-day, high-fat dietAndreas B Jordy, Annette K Serup, Kristian Karstoft, et al.
Journal of Cancer Policy|November 7, 2025
Discrepancies in the therapeutic indications granted by the European Medicines Agency and the US Food and Drug Administration for new cancer drugs: An analysis of potential explanationsAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
The Lancet. Oncology|September 1, 2023
Withdrawn accelerated approvals for cancer indications in the USA: what is the marketing authorisation status in the EU?Allan Cramer, Freja K H Sørup, Hanne R Christensen, et al.
Frontiers in Endocrinology|June 30, 2017
Resting Metabolic Rate Does Not Change in Response to Different Types of Training in Subjects with Type 2 DiabetesKristian Karstoft, Cecilie Fau Brinkløv, Ida Kær Thorsen, et al.
British Journal of Clinical Pharmacology|January 8, 2025
Cancer drug applications to the EMA and the FDA: A comparison of new drugs and extension of indication in terms of approval decisions and time in reviewAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
JAMA Internal Medicine|July 3, 2013
The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitusThomas P J Solomon, Steven K Malin, Kristian Karstoft, et al.
Physiological Reports|August 30, 2014
The immediate effects of a single bout of aerobic exercise on oral glucose tolerance across the glucose tolerance continuumSine H Knudsen, Kristian Karstoft, Bente K Pedersen, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 31, 2007
Different strategies for MRI measurements of renal cortical volumeKristian Karstoft, Anders B Lødrup, Thomas H Dissing, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicityThomas P J Solomon, Sine H Knudsen, Kristian Karstoft, et al.
Pageof 10